CoChat

Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users

Open access
LLOYD-SMITH, E., HULL, M. W., TYNDALL, M. W., ZHANG, R., WOOD, E., MONTANER, J. S. G., KERR, T., ROMNEY, M. G. · 2010 · Epidemiology and Infection

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 1 of the 17 sources its claims cite were checked for support.

Abstract

SUMMARY: Injection drug users (IDUs) have an elevated risk for carriage of Staphylococcus aureus, including methicillin-resistant S. aureus(MRSA). Cutaneous injection-related infections are common in IDUs but detailed studies are few. Based on a subsample of 218 individuals from a community-recruited cohort of IDUs at a supervised injection facility, we investigated the microbiology and related antibiotic susceptibility profiles of isolates from 59 wounds. Twenty-seven percent of subjects had at least one wound and 25 (43%) were culture positive for S. aureus alone [14 MRSA and 11 (19%) methicillin-susceptible (MSSA) isolates]. Sixteen of 18 MRSA isolates were classified as community associated (CA) by the presence of genes encoding for PVL. MRSA and MSSA occurred in mixed infection with other organisms on three and six occasions, respectively. All CA-MRSA isolates were susceptible to tetracycline, vancomycin and linezolid but only 13% were susceptible to clindamycin compared to 63% of MSSA isolates. The frequency of CA-MRSA is a cause for concern in wound infection in the IDU setting.

Overview

CoChat Summary

TL;DR

In a community-recruited cohort of injection drug users at a Vancouver supervised injection facility, 27% had at least one wound and CA-MRSA was common in wound cultures. CA-MRSA isolates were generally susceptible to tetracycline, vancomycin, linezolid, and TMP-SMX but only 13% to clindamycin, raising concern for wound infection treatment.

Key findings

  • Among 218 SEOSI subsample participants, 59 (27%) had at least one wound; most wounds were on the upper extremity (26/59, 44%) or lower extremity (19/59, 32%).
  • Of wounds, 42/59 (71%) had a positive wound culture; CA-MRSA was found in 16/59 (27%) of all wounds, 16/37 (43%) of culture-positive wounds, and 16/18 (89%) of MRSA isolates (Fig. 1). Sixteen of 18 MRSA isolates were classified as community-associated by PVL genes.
  • Polymicrobial infection occurred in 11/42 (26%) culture-positive wounds; MRSA and MSSA occurred in mixed infection with other organisms on three and six occasions, respectively.
  • All CA-MRSA isolates were susceptible to tetracycline, rifampin, vancomycin, and linezolid; TMP-SMX susceptibility was 94%, while only 13% of CA-MRSA isolates were susceptible to clindamycin compared with 63% of MSSA isolates.

Methods

  • Sub-study within the Scientific Evaluation of Supervised Injection (SEOSI) cohort at Vancouver’s supervised injection facility, conducted 7 July–28 November 2008; all SEOSI participants were eligible, and 218 participants had a questionnaire and one wound swab collected by a physician or study nurse.
  • Wound swabs were cultured for aerobic organisms; MRSA was identified with selective chromogenic medium and confirmed by cefoxitin disk testing and/or PBP2a detection plus PCR for *mecA* and *nuc*; CA-MRSA was classified by PCR detection of LukS-PV and LukF-PV genes encoding PVL.
  • Antimicrobial susceptibility was determined by automated micro-broth testing per CLSI guidelines, with Kirby-Bauer testing and clindamycin D-test as needed; baseline characteristics were compared using Pearson’s χ² test and Wilcoxon rank sum test in SAS 9.1, with two-sided P≤0.05 considered significant.

Limitations

  • The paper states this was a convenience sample of SEOSI participants who visited the research office during recruitment; participants with intense drug use or serious medical conditions may have been less likely to attend, potentially underestimating wounds and CA-MRSA.
  • The paper states antibiotic use was collected for the previous 6 months but not current use, so individuals on antibiotics at specimen collection may have had culture-negative wounds; wound size was not recorded, and the subsample may not represent the IDU community in this or other settings.
  • Evident from the text: isolate numbers were small (e.g., 16 CA-MRSA), and reported denominators vary between the Results (42 positive wound cultures) and Fig. 1 (37 culture-positive wounds), which limits precision.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1017/s0950268810000464

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Microbiology distribution of wounds in a subsample of the Scientific Evaluation of Supervised Injection cohort. * Denotes CA-MRSA ( n = 16): in all wounds (16/59, 27%); in culture-positive wounds (16/37, 43%); in MRSA (16/18, 89%).
Fig. 1 Microbiology distribution of wounds in a subsample of the Scientific Evaluation of Supervised Injection cohort. * Denotes CA-MRSA ( n = 16): in all wounds (16/59, 27%); in culture-positive wounds (16/37, 43%); in MRSA (16/18, 89%).From the PDF

Verification

Claims the paper makes

1 Valid · 0 Not valid · 11 Not checked · 23 Own results and interpretations

9 more claims

Create a free account to see all 35 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 27 references

Research works printed but not linked: 1

  1. 2006, Performance standards for antimicrobial susceptibility testing. Supplement M100-S16

Cited by

See all 35

Metadata

Authors
LLOYD-SMITH, E., HULL, M. W., TYNDALL, M. W., ZHANG, R., WOOD, E., MONTANER, J. S. G., KERR, T., & ROMNEY, M. G.
Affiliations
  • University of British Columbia (CA)
  • St. Paul's Hospital (CA)
Corresponding author
ROMNEY, M. G.
Venue
Epidemiology and Infection
Published
2010-03-05
Volume
138
Issue
5
Pages
713-720
ISSN
  • 0950-2688 (ISSN-L)
  • 1469-4409
OpenAlex
W2140936069
Cited by
35
References
27
Citations by year
2025: 1 · 2023: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 4
FWCI
3.72
Type
journal article
Language
en
Open access
Locations
  • Epidemiology and Infection (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • Canadian Institutes of Health Research (85526_1, RAA- 79918)
  • National Institute on Drug Abuse (DP1DA026182)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords
community-acquired MRSA, methicillin-resistant Staphylococcus aureus, methicillin-susceptible Staphylococcus aureus, people who inject drugs, wound infection, injection-related infections, Panton-Valentine leukocidin, antibiotic susceptibility, clindamycin resistance, supervised injection facilities, co-infection
MeSH terms
Adult, Anti-Bacterial Agents, Bacterial Toxins, Exotoxins, Female, Humans, Leukocidins, Male, Microbial Sensitivity Tests, Staphylococcal Infections, Wound Infection, Substance Abuse, Intravenous, Comorbidity, Prevalence, Methicillin Resistance, Community-Acquired Infections, Drug Users, Methicillin-Resistant Staphylococcus aureus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. https://app.cochat.ai/papers/10.1017/s0950268810000464
The paper
LLOYD-SMITH, E., HULL, M. W., TYNDALL, M. W., ZHANG, R., WOOD, E., MONTANER, J. S. G., KERR, T., & ROMNEY, M. G. (2010). Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users. Epidemiology and Infection. https://doi.org/10.1017/s0950268810000464

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.